Harrison Wise

Founder, Publisher and Contributing Editor at The Bluntness, Inc. Harrison is also the founder and CEO of Wise Collective, an award-winning integrated marketing communications agency that works across the Cannabis, Tech, Sports, Media and Entertainment industries. Harrison has been involved in the Cannabis industry since 2015 when he and his agency launched MedMen. They have since worked with and counseled countless businesses and brands in the cannabis industry, including but not limited to Stiiizy, Shryne Group, Cloudponics, MCR Labs, Chil, Hemptown USA, Happy Valley MA and Greatest Hits Cannabis Co. among others. For more information visit: www.wisecollective.co.

a figurine face of Donald Trump on top of $100 bills, money

Cannabis stocks surge after Trump signal

President Donald Trump has directed federal agencies to begin reclassifying marijuana from Schedule I to Schedule III under the Controlled Substances Act. The move formally recognizes cannabis’ medical value and sets the stage for expanded research and potential tax relief for operators. Industry leaders broadly applaud the decision as historic, while cautioning that rescheduling is a foundation, not a finish line.

protesters holding sign, peaceful, democracy

Hemp Ban Threatens $28B Industry

Congress is attempting to recriminalize most hemp products by redefining "hemp" in the federal spending package, threatening to wipe out 90–95% of a thriving $28+ billion industry. This isn't consumer protection; it's economic sabotage that would devastate farmers, destroy hundreds of thousands of jobs, eliminate billions in tax revenue, and push demand underground. The solution already exists: national standards with age-gating, testing, labeling, and responsible placement. If you work in, buy from, or care about this industry, you have 48–72 hours to make your voice heard.

Meta’s Moderation Double Standard? Cannabis & Psychedelics vs. Sex-and-Violence Content

Editorial

Meta's Hypocrisy: Drugs vs. Sex/Violence

TL;DR: In 2025 Meta ended its U.S. third-party fact-checking and began rolling out Community Notes across Facebook, Instagram and Threads, changing how “borderline” posts are handled. On paper, Meta’s Restricted Goods & Services rules allow debate and education about high-risk drugs while banning sales coordination. In practice, cannabis and psychedelics educators and nonprofits continue to report takedowns, suspensions, and “not eligible for recommendations” labels, even as other sensational content is frequently visible. The problem isn’t only “censorship”; it’s uneven, error-prone enforcement that undermines legitimate health and science discourse.